AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
MGRCX
Price
$44.20
Change
+$0.41 (+0.94%)
Updated
Oct 3 closing price
Net Assets
21.91B
Interact to see
Advertisement

AEPCX vs MGRCX

Header iconAEPCX vs MGRCX Comparison
Open Charts AEPCX vs MGRCXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
MFS International Growth C
Price$44.20
Change+$0.41 (+0.94%)
VolumeN/A
Net Assets21.91B
AEPCX vs MGRCX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. MGRCX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and MGRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. MGRCX (21.9B). MGRCX pays higher dividends than AEPCX: MGRCX (0.51) vs AEPCX (0.16). AEPCX was incepted earlier than MGRCX: AEPCX (25 years) vs MGRCX (29 years). MGRCX (1.85) is less costly to investors than AEPCX (1.57). AEPCX is a more actively managed with annual turnover of: 35.00 vs. MGRCX (20.00). AEPCX has a lower initial minimum investment than MGRCX: AEPCX (250) vs MGRCX (1000). AEPCX annual gain was more profitable for investors over the last year : 10.37 vs. MGRCX (7.75). MGRCX return over 5 years is better than : 29.48 vs. AEPCX (13.86).
AEPCXMGRCXAEPCX / MGRCX
Total Expense Ratio1.571.8485%
Annual Report Gross Expense Ratio1.571.8585%
Fund Existence25 years29 years-
Gain YTD21.48220.963102%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets139B21.9B635%
Annual Yield % from dividends0.160.5131%
Returns for 1 year10.377.75134%
Returns for 3 years42.8247.1691%
Returns for 5 years13.8629.4847%
Returns for 10 years39.9589.0445%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital